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Abstract
Commentary on
Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia
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S Boneva, Marjorie Morrissey and Rebecca Devlin
One of the most difficult tasks in medicine is to accurately
measure how common illnesses are. Why do we do it? Jus-
tifications include being able to plan health care and pub-
lic health priorities, as well as highlighting specific
diseases for extra funding for both health care and
research. Yet the jobbing physician at the sharp edge of
clinical practice cares little about the exact prevalence of a
disease or illness, since this is all too obvious from the fre-
quency of the problems presented by patients who come
through the door.
How do you measure a syndrome?
If the disease in question has no biological marker and is
difficult to define clinically, the problem of working out
the accurate prevalence becomes esoteric. Chronic fatigue
syndrome (CFS) is just such an illness. It has as many syn-
onyms as putative causes, being also called myalgic
encephalomyelitis, chronic immune dysfunction syn-
drome, and post-viral fatigue syndrome, amongst others.
Since fatigue is one of the most common symptoms
reported by patients in general, delineating a specific syn-
drome with fatigue as a central feature risks arbitrary deci-
sions about ascertainment. Do we categorise the
syndrome on the basis of the severity of fatigue, the
number of associated symptoms, or the severity of the
resultant disability? Even measuring the consequent disa-
bility gives us problems since there are only weak correla-
tions between subjective and objective observations [1]. It
is therefore no great surprise that half of all doctors do not
even believe it exists [2].
And yet, patients and their organisations constantly criti-
cize doctors both for not believing in the existence of CFS
and for not taking patients seriously. Even politicians
seem to take the problem more seriously than some doc-
tors do. This may be as much to do with successful lobby-
ing as the economic costs of CFS, which have been
estimated as $9 billion per annum just for lost productiv-
ity in the USA [3]. Doctors don't understand things they
can't see or measure, and patients mistrust doctors who
don't understand them. We are in a conundrum.
One way forward
The Centers for Disease Control and Prevention (CDC) in
the United States of America are one of the few health care
agencies who do take CFS seriously, to the extent of sup-
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porting a $4 million public education campaign, which
started last year [4]. They have also led the way in provid-
ing operationalised criteria in order to standardize the
diagnosis of CFS [5]. Their latest research programme has
been based on a large survey of the adult (18–59 years
old) population of the state of Georgia, USA, in order to
better understand the epidemiology and etiology of CFS
[6]. Their previous study of prevalence, in Wichita, Kan-
sas, suggested a prevalence of 0.24% [7]. Another inde-
pendent population survey in Chicago suggested a
prevalence of 0.42% [8]. The CDC has now repeated and
extended the Wichita study in Georgia, and found a prev-
alence of between six and ten times greater, with 2.5% of
the population suffering from CFS [6]. If this prevalence
was both accurate and representative of the USA as a
whole, this would suggest that some 7.5 million Ameri-
cans were sufferers, compared to the previous estimates of
0.7 to 1.2 million.
A cautious interpretation
Could this really be true? The authors are sensibly cau-
tious in their interpretations, and point out the uncertain-
ties inherent within the study. There are three main
reasons why we should be cautious about interpretation
and generalizing from this finding. Compared to previous
studies, there were important differences in the method of
ascertainment used in the Georgia study that may help to
explain the greater prevalence. Most importantly, the
Georgia study used a different initial screening question.
Instead of asking whether a household member was suf-
fering from "fatigue", as previously done, the screening
question asked about being "unwell", by which was
meant having one or more of the following symptoms for
a month or more: "fatigue, cognitive impairment, unre-
freshing sleep, muscle pain, joint pain, sore throat, tender
lymph nodes, or headache" (all being likely symptoms of
CFS). The authors suggested that this stratagem picked up
an extra 11.5% of CFS cases. A strength of the Georgia sur-
vey was the use of standardised measures of symptoms
and disability. However in order to count someone as
fatigued – the central criterion for a diagnosis of CFS –
individuals only needed to score the median or more of
the well population, either for fatigue or inactivity. In a
previous study, the same authors found that using such
standardised measures picked up three times as many
cases of CFS than verbatim enquiries [9]. These methodo-
logical differences mean it is not possible to directly com-
pare the prevalence of CFS in Georgia with previous
studies.
Comorbid psychiatric conditions may have inflated the
prevalence. A previous study found an equally high point
prevalence of CFS (2.6%), by surveying United Kingdom
primary care patients [10]. However, when those patients
who also had a comorbid psychiatric disorder were
excluded, the prevalence fell to 0.5%. Although it will be
important to publish the prevalence of comorbid psychi-
atric disorders in the Georgian survey, the argument can
still be put that these comorbid psychiatric disorders were
secondary to having chronic ill-health, rather than the pri-
mary and explanatory condition. The current design can-
not determine the direction of causality, although
previous longitudinal studies suggest that psychiatric ill
health can both follow and precede CFS [11,12].
Georgia may not be representative of the USA as a whole.
For instance, we do not know the body mass index (BMI)
of the Georgian sample. The Wichita sample of CFS cases
contained 43% of subjects with a BMI of 30 or over, rep-
resenting significant obesity [9]. This compares with 20%
in the USA as a whole [13]. Since obesity is associated
with fatigue [14], a similar proportion in Georgia might
inflate the prevalence of CFS.
To conclude
What can we conclude from this very large survey?
Although methodological issues may help to explain the
high prevalence of CFS found in this study, the argument
can still be made that the prevalence of CFS is greater than
previously thought [10,15]. CFS is at least as common in
ethnic minorities in the USA as in the ethnic Caucasian
majority; a welcome replication of previous studies [8].
CFS is not an exclusively white syndrome. Social issues
may help to explain why women suffer CFS more than
men. But perhaps the most important conclusion is that
there were about twice as many people in Georgia who
were unwell with fatigue, who did not meet the criteria for
CFS. Our current criteria for diagnosing CFS are arbitrary
[16], and we need to widen the net to capture all those
people who become so chronically tired and unwell that
they can't live their lives to their full potential. The job-
bing physician does not close the door on those who
don't meet criteria.
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